NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Don’t think machine, think space and places along the process where certain things take place in a highly controlled environment, for the cartridge.

I said I think that will likely be version 2.0, though I think your ideas are not taking into account their scaled up Eden version.

And nothing has to be exclusive Gary. They can create a system that is parallel and more scalable that uses space more efficiently and is not a desktop printer that can be sent to other sites. They can do all kinds of things with a process and engineers. They can even send desktop printers if that makes the most sense for a particular iteration of a CDMO’s operation in a particular location or country. But they don’t have to make a consumer product, so it can be engineered for scaling and a manufacturing environment, not just for a small lab.

I know one of your early ideas and you may still be hanging onto this notion, that they are going to sell just the “desktop printers”, not even make DCVax and let the local hospital make it. That is not what they will be licensed to do and there is no way they would do that, as that would not be protectable and they’d basically be giving up a profitable custom cancer cure business to make “desktop printers” for a few hospitals in the world. That a terrible business and, as I said, that is not what they are licensed for. Every hospital would need a GMP certification to make DCVax, it makes no sense. But using their space in their factory more efficiently over time to make more vaccine on the same footprint, that is how factories actually scale.